John Hathaway - Jun 30, 2025 SCHEDULE 13G/A Report for Medicus Pharma Ltd. Common shares, no par value (MDCX)

Filing Manager: Hathaway John Jason
Reporting Manager: John Hathaway
Security: Medicus Pharma Ltd. Common shares, no par value
Symbol: MDCX
Shares outstanding: 17.8M shares
Disclosed Ownership: 801K shares
Ownership: 4.5%
Form type: SCHEDULE 13G/A
Date filed: 8/12/2025, 09:00 AM
Date of event: Jun 30, 2025
Previous filing: Feb 10, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Hathaway	4.5%	801K	801K	0	/s/ John Hathaway	John Hathaway
SkinJect Partners LLC	4.5%	801K	801K	0	/s/ John Hathaway	John Hathaway, Managing Director